1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


TABLE 2: 
Association between diseased optic nerve ADC and clinical and electrophysiologic measurements
SRCCP Value
logMAR visual acuity0.730.001
30-2 Humphrey mean deviation (dB)−0.80<0.001
FM 100 Hue square root of error score0.83<0.001
VEP whole-field amplitude (μV)−0.640.008
VEP whole-field latency (ms)0.580.019
VEP central-field amplitude (μV)−0.570.021
VEP central-field latency (ms)0.580.019
  • Note.—FM 100 Hue, Farnsworth Munsell 100 Hue test; SRCC, Spearman’s rank correlation coefficient; VEP = visual evoked potentials.